Actively hiring
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
CellFiber and Tidewave Bio Enter Collaboration to Evaluate Scalable 3D Manufacturing for Next-Generation Solid Tumor Immunotherapy
TOKYO and LOS ANGELES, Aug. 05, 2026 (GLOBE NEWSWIRE) -- CellFiber Co., Ltd. (
Read more
Report
CellFiber and Tidewave Bio Enter Collaboration to Evaluate Scalable 3D Manufacturing for Next-Generation Solid Tumor Immunotherapy
Partnership pairs CellFiber's proprietary hollow-fiber encapsulation platform with Tidewave Bio's universal, off-the-shelf cell immunotherapy program in a proof-of-concept process evaluation
Read more
Report
A new way to use Tidewave: from your terminal or editor
Use Tidewave from your terminal or editor: point at UI with the Toolbar, or let your agent see and drive your running app with Connect.
Read more
Report
CellFiber and Tidewave Bio Enter Collaboration to Evaluate Scalable 3D Manufacturing for ...
Read more
Report
You don't need ten agents. You need two tracks.
A practical two-track workflow for using coding agents in parallel: write specs with one agent, then let another implement them.
Read more
Report
Designing Tidewave's Git integration
A deep dive into the design of Tidewave's Git status bar, from commits and pushes to pull requests, CI failures, and agent-driven workflows.
Read more
Report
A new direction for AI developer tooling featuring José Valim, creator of Tidewave (Changelog & Friends #112)
Elixir creator, José Valim, is throwing his hat into the coding agent ring with Tidewave -a coding agent for full-stack web development. Tidewave runs in the browser alongside your app, but it's also deeply integrated into Rails and Phoenix. On this episo
Read more
Report
Designing code review for human-agent collaboration
Tidewave now includes the ability to review code, focusing on real-time and collaborative capabilities.
Read more
Report
Tidewave Bio Appoints Prof. Alexander M.M. Eggermont, MD, PhD, as Head of Clinical Advisory Board
LOS ANGELES, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Tidewave Bio, a biotechnology company developing a universal, biopsy-native immunotherapy platform for solid tumors, today announced the appointment ofProf. Alexander M.M. Eggermont, MD, PhD, as Head of its C
Read more
Report
Show more news
